Purchase this article with an account.
Donald J Zack; Application of CRISPR/Cas9 to the study and treatment of retinal disease. Invest. Ophthalmol. Vis. Sci. 201657(12):.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Presentation Description :
Challenges remain, but CRISPR/Cas9 technology is rapidly moving toward potential clinical development. This presentation will highlight some of the targets that are being pursued in the retina and technological advances that may assist the translation of this exciting technology into a viable therapeutic approach.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
This PDF is available to Subscribers Only